Topline Eli Lilly, the GLP-1 maker behind Mounjaro and Zepbound, said it would file for Food and Drug Administration approval of its powerful retatrutide weight-loss drug after studies found participants lost an average of nearly 56 pounds after 80 weeks on the medication
These might include stress, diet, physical activity, sleep, medications, and more
Managing Fatigue Safely Whilst Taking Retatrutide Maintaining adequate protein, complex carbohydrates, and fluid intake, pacing activity, and avoiding alcohol are key evidence-informed strategies for managing retatrutide fatigue safely
They need connected booking, compliance, and workflows
On top of that, one of the biggest complaints about GLP-1s, when taken according to the standard doses approved by the FDA is that they cause side effects such as nausea, diarrhea and fatigue
See how medical spa booking software became part of the client experience and why connected scheduling now matters